Pigmented Lesion Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Key Highlights

• The Pigmented Lesion Treatment market is anticipated to grow with a CAGR of nearly 5.9%, during the forecast period.
• Certain factors that are driving the market growth include rising geriatric population and increasing prevalence of pigmentation disorders.
• As per the revised World Population Prospects, by the United Nations, the number of people aged 60 or above is expected to grow greater than double by 2050, i.e. from 962 million in 2017 to 2.1 billion in 2050, globally. This age group is highly vulnerable to different types of age-related diseases that require personal mobility aid.
• With the increase in age, despite the decreased melanocyte density, photoaged skin has irregular pigmentation and, frequently, there is hyperpigmentation. This may be due to greater positivity of dopa of chronically irradiated melanocytes. This afore-mentioned factor is expected to contribute to the market growth over the forecast period.

Key Market Trends

Lasers and Energy Based Devices Hold Significant Share in the Global Pigmented Lesion Treatment Market

• Medical laser based devices are used for the treatment of various skin diseases including pigmented lesions.
• The rising demand for treatment procedures with faster recovery, fewer post-treatment infections, less pain, reduced scarring, better control on bleeding, and increased accuracy are anticipated to boost the demand for various laser devices.
• Technological advances in therapeutic techniques and enhancement in equipment handling have transformed treatment procedures, including the introduction of laser and energy based treatments for pigmented lesions.

North America Dominates the Global Pigmented Lesion Treatment Market

• North America dominates the global pigmented lesions treatment market owing to the rising pigmentation disorders. Presence of well-established healthcare infrastructure and major market players providing effective treatment options to the patients suffering with post-inflammatory hyperpigmentation in North America.
• Asia Pacific region is experiencing a swift pace in the global pigmented lesions treatment market due to the increasing beauty consciousness among Asians, rapid entry of new players into the market and expansion by the major players into the emerging economies.

Competitive Landscape

The global Pigmented Lesion Treatment market is moderately competitive and consists of a few major players. Companies like Alma Lasers Ltd., Cutera Inc., Cynosure, Inc., Lumenis Ltd., Lutronic Corporation, Lynton Lasers Ltd, Solta Medical Inc., Strata Skin Sciences Inc., Syneron Medical Ltd., among others, hold the substantial market share in the market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support